484 related articles for article (PubMed ID: 16481330)
1. Transcriptional regulation of the human GD3 synthase gene expression in Fas-induced Jurkat T cells: a critical role of transcription factor NF-kappaB in regulated expression.
Kang NY; Kang SK; Lee YC; Choi HJ; Lee YS; Cho SY; Kim YS; Ko JH; Kim CH
Glycobiology; 2006 May; 16(5):375-89. PubMed ID: 16481330
[TBL] [Abstract][Full Text] [Related]
2. Expression of the human CMP-NeuAc:GM3 alpha2,8-sialyltransferase (GD3 synthase) gene through the NF-kappaB activation in human melanoma SK-MEL-2 cells.
Kang NY; Kim CH; Kim KS; Ko JH; Lee JH; Jeong YK; Lee YC
Biochim Biophys Acta; 2007; 1769(11-12):622-30. PubMed ID: 17913261
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the human intestinal CD98 promoter and its regulation by interferon-gamma.
Yan Y; Dalmasso G; Sitaraman S; Merlin D
Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G535-45. PubMed ID: 17023546
[TBL] [Abstract][Full Text] [Related]
4. T cell activation-induced and HIV tat-enhanced CD95(APO-1/Fas) ligand transcription involves NF-kappaB.
Li-Weber M; Laur O; Dern K; Krammer PH
Eur J Immunol; 2000 Feb; 30(2):661-70. PubMed ID: 10671224
[TBL] [Abstract][Full Text] [Related]
5. Involvement of activator protein-1 and nuclear factor-kappaB transcription factors in the control of the DT-diaphorase expression induced by mitomycin C treatment.
Yao KS; Hageboutros A; Ford P; O'Dwyer PJ
Mol Pharmacol; 1997 Mar; 51(3):422-30. PubMed ID: 9058597
[TBL] [Abstract][Full Text] [Related]
6. In vivo binding of NF-kappaB to the IkappaBbeta promoter is insufficient for transcriptional activation.
Griffin BD; Moynagh PN
Biochem J; 2006 Nov; 400(1):115-25. PubMed ID: 16792530
[TBL] [Abstract][Full Text] [Related]
7. The classical and a non-classical pathways associated with NF-kappaB are involved in estrogen-mediated regulation of calbindin-D9k gene in rat pituitary cells.
Lee GS; Choi KC; Han HJ; Jeung EB
Mol Cell Endocrinol; 2007 Oct; 277(1-2):42-50. PubMed ID: 17825480
[TBL] [Abstract][Full Text] [Related]
8. rel/NF-kappa B nuclear complexes that bind kB sites in the murine c-rel promoter are required for constitutive c-rel transcription in B-cells.
Grumont RJ; Richardson IB; Gaff C; Gerondakis S
Cell Growth Differ; 1993 Sep; 4(9):731-43. PubMed ID: 8241021
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the infection-responsive bovine lactoferrin promoter.
Zheng J; Ather JL; Sonstegard TS; Kerr DE
Gene; 2005 Jun; 353(1):107-17. PubMed ID: 15935571
[TBL] [Abstract][Full Text] [Related]
10. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.
Huerta-Yepez S; Vega M; Garban H; Bonavida B
Clin Immunol; 2006 Sep; 120(3):297-309. PubMed ID: 16784892
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the epidermal growth factor receptor promoter: the effect of nuclear factor-kappaB.
Nishi H; Neta G; Nishi KH; Akers LM; Rikiyama T; Proctor KN; Murphy BA; Johnson AC
Int J Mol Med; 2003 Jan; 11(1):49-55. PubMed ID: 12469217
[TBL] [Abstract][Full Text] [Related]
12. Human T-cell leukemia virus type-I oncoprotein Tax inhibits Fas-mediated apoptosis by inducing cellular FLIP through activation of NF-kappaB.
Okamoto K; Fujisawa J; Reth M; Yonehara S
Genes Cells; 2006 Feb; 11(2):177-91. PubMed ID: 16436054
[TBL] [Abstract][Full Text] [Related]
13. Platycodin D-induced apoptosis through nuclear factor-kappaB activation in immortalized keratinocytes.
Ahn KS; Hahn BS; Kwack K; Lee EB; Kim YS
Eur J Pharmacol; 2006 May; 537(1-3):1-11. PubMed ID: 16631160
[TBL] [Abstract][Full Text] [Related]
14. Human T-cell leukemia virus type I Tax transactivates human interleukin 8 gene through acting concurrently on AP-1 and nuclear factor-kappaB-like sites.
Mori N; Mukaida N; Ballard DW; Matsushima K; Yamamoto N
Cancer Res; 1998 Sep; 58(17):3993-4000. PubMed ID: 9731513
[TBL] [Abstract][Full Text] [Related]
15. Transcription of the RelB gene is regulated by NF-kappaB.
Bren GD; Solan NJ; Miyoshi H; Pennington KN; Pobst LJ; Paya CV
Oncogene; 2001 Nov; 20(53):7722-33. PubMed ID: 11753650
[TBL] [Abstract][Full Text] [Related]
16. Identification of two NF-kappa B sites in mouse CD95 ligand (Fas ligand) promoter: functional analysis in T cell hybridoma.
Matsui K; Fine A; Zhu B; Marshak-Rothstein A; Ju ST
J Immunol; 1998 Oct; 161(7):3469-73. PubMed ID: 9759866
[TBL] [Abstract][Full Text] [Related]
17. Activation of the wt1 Wilms' tumor suppressor gene by NF-kappaB.
Dehbi M; Hiscott J; Pelletier J
Oncogene; 1998 Apr; 16(16):2033-9. PubMed ID: 9572484
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the human CIDEA promoter in fat cells.
Pettersson AT; Laurencikiene J; Nordström EA; Stenson BM; van Harmelen V; Murphy C; Dahlman I; Rydén M
Int J Obes (Lond); 2008 Sep; 32(9):1380-7. PubMed ID: 18607384
[TBL] [Abstract][Full Text] [Related]
19. EGF stimulates uPAR expression and cell invasiveness through ERK, AP-1, and NF-kappaB signaling in human gastric carcinoma cells.
Baek MK; Kim MH; Jang HJ; Park JS; Chung IJ; Shin BA; Ahn BW; Jung YD
Oncol Rep; 2008 Dec; 20(6):1569-75. PubMed ID: 19020743
[TBL] [Abstract][Full Text] [Related]
20. Caffeic acid phenethyl ester inhibits T-cell activation by targeting both nuclear factor of activated T-cells and NF-kappaB transcription factors.
Márquez N; Sancho R; Macho A; Calzado MA; Fiebich BL; Muñoz E
J Pharmacol Exp Ther; 2004 Mar; 308(3):993-1001. PubMed ID: 14617683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
